[1]
“Gasser cell: A biomarker of response to enzyme replacement therapy in patients with mucopolysaccharidosis type VI”, RSD, vol. 10, no. 5, p. e24510514726, May 2021, doi: 10.33448/rsd-v10i5.14726.